OneMedNet Corp — Director's Dealing 2025

Nov 27, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OneMedNet Corp (ONMD)
CIK: 0001849380
Period of Report: 2024-02-01

Reporting Person: Yu Jeffrey (Director, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-01	Common Stock	P	1357	$1.45	Acquired	2524243	Direct
2024-02-08	Common Stock	P	2	$1.19	Acquired	2524245	Direct
2024-02-16	Common Stock	P	100	$0.82	Acquired	2524345	Direct
2024-03-06	Common Stock	P	16	$0.84	Acquired	2524361	Direct
2024-03-22	Common Stock	P	100	$0.79	Acquired	2524461	Direct
2024-04-24	Common Stock	P	100	$0.65	Acquired	2524561	Direct
2024-05-02	Common Stock	P	100	$0.62	Acquired	2524661	Direct
2024-05-03	Common Stock	P	350	$0.6	Acquired	2525011	Direct
2024-05-06	Common Stock	P	214	$0.65	Acquired	2525225	Direct
2024-05-07	Common Stock	P	106	$0.68	Acquired	2525331	Direct
2024-05-08	Common Stock	P	105	$0.69	Acquired	2525436	Direct
2024-05-10	Common Stock	P	1203	$0.52	Acquired	2526639	Direct
2024-08-12	Common Stock	P	913	$1.1	Acquired	2527552	Direct
2024-08-13	Common Stock	P	2237	$1.19	Acquired	2529789	Direct
2024-08-14	Common Stock	P	13	$1.35	Acquired	2529802	Direct
2024-08-15	Common Stock	P	10	$1.34	Acquired	2529812	Direct
2024-08-16	Common Stock	P	14	$1.41	Acquired	2529826	Direct
2024-08-21	Common Stock	P	100	$1.22	Acquired	2529926	Direct
2024-09-18	Common Stock	P	800	$0.68	Acquired	2530726	Direct
2024-09-20	Common Stock	P	1600	$0.66	Acquired	2532326	Direct
2024-10-01	Common Stock	A	230769	$0.57	Acquired	2763095	Direct
2024-12-18	Common Stock	P	100	$0.99	Acquired	2763195	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1311970	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.38 to $1.55, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnotes of this report.

F2: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.59 to $0.61, inclusive.

F3: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.61 to $0.67, inclusive.

F4: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.66 to $0.69, inclusive.

F5: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.50 to $0.55, inclusive.

F6: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.06 to $1.16, inclusive.

F7: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.16 to $1.25, inclusive.

F8: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.33 to $1.37, inclusive.

F9: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.36 to $1.46, inclusive.

F10: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.65 to $0.71, inclusive.

F11: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.62 to $0.66, inclusive.

F12: Represents restricted stock units ("RSUs") issued in lieu of cash compensation, which RSUs vested in full on July 1, 2025. Each RSU represents the contingent right to receive one share of the issuer's common stock.

F13: The shares are held by trust with an independent trustee, in which the reporting person has no investment control. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.